Practice guidelines Non-invasive diagnosis and follow-up of primary biliary cholangitis

被引:4
|
作者
Corpechot, Christophe [1 ,2 ]
Heurgue, Alexandra [3 ]
Tanne, Florence [6 ]
Potier, Pascal [7 ]
Hanslik, Bertrand [8 ]
Decraecker, Marie [4 ,5 ]
de Ledinghen, Victor [4 ,5 ]
Ganne-Carrie, Nathalie [9 ,10 ]
Bureau, Christophe [11 ]
Bourliere, Marc [12 ,13 ]
机构
[1] Hop St Antoine, AP HP, Serv Hepatogastroenterol, 184 Rue Faubourg St Antoine, F-75012 Paris, France
[2] Univ Paris Sorbonne, Reference Ctr Inflammatory Biliary Dis & Autoimmu, French Network Rare Liver Dis Children & Adults F, European Reference Network Rare Hepatol Dis ERN R, Paris, France
[3] CHU Reims, Serv Hepatogastroenterol & Cancerol Digest, Reims, France
[4] CHU Bordeaux, Hop Haut Leveque, Serv Hepatogastroenterol, Pessac, France
[5] Univ Bordeaux, INSERM U1053, Bordeaux, France
[6] CHRU Brest Cavale Blanche, Serv Hepatogastroenterol, Brest, France
[7] CHR Orleans, Serv Hepatogastroenterol & Oncol Digest, Orleans, France
[8] Ctr Montpellierain Malad Foie & Appareil Digestif, Montpellier, France
[9] Univ Sorbonne Paris Nord, Hop Avicenne, AP HP, Serv Hepatol, Bobigny, France
[10] Univ Paris, Ctr Rech Cordeliers, INSERM UMR 1138, Paris, France
[11] CHU Toulouse, Serv Hepatol, Hop Rangueil, Toulouse, France
[12] Aix Marseille Univ, Serv Hepatogastroenterol, Hop St Joseph, Marseille, France
[13] Aix Marseille Univ, INSERM UMR 1252 IRD SESSTIM, Marseille, France
关键词
PBC; ACID-TREATED PATIENTS; URSODEOXYCHOLIC ACID; BIOCHEMICAL RESPONSE; GRADING SYSTEM; CIRRHOSIS; PROGNOSIS; PROGRESSION; RISK; PREDICTION; SURVIVAL;
D O I
10.1016/j.clinre.2021.101770
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Primary biliary cholangitis (PBC) is a chronic inflammatory disease of the intra-hepatic bile ducts [1] . It is characterised biologically by chronic cholestasis associated with the presence of specific autoantibodies, and histologically by lesions of nonsuppurative destructive cholangitis. If left untreated it can progress to cirrhosis, portal hypertension and liver failure. Diagnosis, staging and follow-up are largely based on non-or minimally-invasive assessment (blood tests, ultrasound, liver stiffness measurement). Histological examination of the liver and upper gastrointestinal endoscopy are sometimes necessary, but their indications remain limited. The purpose of this chapter is to provide the clinicians with what should be known about the non-invasive assessment of PBC and to provide specific recommendations for clinical practice. (c) 2021 Elsevier Masson SAS. All rights reserved.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Non-invasive diagnosis and follow-up of primary sclerosing cholangitis
    Chazouilleres, Olivier
    Potier, Pascal
    Bouzbib, Charlotte
    Hanslik, Bertrand
    Heurgue, Alexandra
    NGuyen-Khac, Eric
    Gournay, Jerome
    Tanne, Florence
    Bureau, Christophe
    Bourliere, Marc
    Ganne-Carrie, Nathalie
    de Ledinghen, Victor
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2021, 46 (01)
  • [2] Non-invasive diagnosis and follow-up of hyperferritinaemia
    Bardou-Jacquet, Edouard
    Hamdi-Roze, Houda
    Paisant, Anita
    Decraecker, Marie
    Bourliere, Marc
    Ganne-Carrie, Nathalie
    de Ledinghen, Victor
    Bureau, Christophe
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2022, 46 (01)
  • [3] Non-invasive diagnosis and follow-up of primary malignant liver tumours
    Nahon, Pierre
    Aube, Christophe
    Moga, Lucile
    Chalaye, Julia
    Guiu, Boris
    Luciani, Alain
    Rode, Agnes
    Ronot, Maxime
    Seror, Olivier
    Soussan, Michael
    Sutter, Olivier
    Bourliere, Marc
    Bureau, Christophe
    de Ledinghen, Victor
    Ganne-Carrie, Nathalie
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2022, 46 (01)
  • [4] Non-invasive diagnosis and follow-up in liver transplantation
    Dumortier, Jerome
    Besch, Camille
    Moga, Lucile
    Coilly, Audrey
    Conti, Filomena
    Corpechot, Christophe
    Del Bello, Arnaud
    Faitot, Francois
    Francoz, Claire
    Hilleret, Marie-Noelle
    Houssel-Debry, Pauline
    Jezequel, Caroline
    Lavayssiere, Laurence
    Neau-Cransac, Martine
    Erard-Poinsot, Domitille
    de Ledinghen, Victor
    Bourliere, Marc
    Bureau, Christophe
    Ganne-Carrie, Nathalie
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2022, 46 (01)
  • [5] Non-invasive diagnosis and follow-up of autoimmune hepatitis
    Lemoinne, Sara
    Heurgue, Alexandra
    Bouzbib, Charlotte
    Hanslik, Bertrand
    Gournay, Jerome
    Nguyen-Khac, Eric
    Bureau, Christophe
    de Ledinghen, Victor
    Ganne-Carrie, Nathalie
    Bourliere, Marc
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2022, 46 (01)
  • [6] Non-invasive diagnosis and follow-up of portal hypertension
    Thabut, Dominique
    Weil, Delphine
    Bouzbib, Charlotte
    Rudler, Marika
    Cassinotto, Christophe
    Castera, Laurent
    Serste, Thomas
    Oberti, Frederic
    Ganne-Carrie, Nathalie
    de Ledinghen, Victor
    Bourliere, Marc
    Bureau, Christophe
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2022, 46 (08)
  • [7] Non-invasive diagnosis and follow-up of chronic liver disease
    de Ledinghen, Victor
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2022, 46 (01) : 1 - 2
  • [8] Non-invasive diagnosis and follow-up of benign liver tumours
    Nault, Jean-Charles
    Blanc, Jean-Frederic
    Moga, Lucile
    Calderaro, Julien
    Dao, Thong
    Guiu, Boris
    Hocquelet, Arnaud
    Paradis, Valerie
    Salame, Ephrem
    de Ledinghen, Victor
    Bourliere, Marc
    Bureau, Christophe
    Ganne-Carrie, Nathalie
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2022, 46 (01)
  • [9] Non-invasive diagnosis and follow-up of vascular liver diseases
    Rautou, Pierre-Emmanuel
    Elkrief, Laure
    Decraecker, Marie
    Ollivier-Hourmand, Isabelle
    Plessier, Aurelie
    Ronot, Maxime
    Vilgrain, Valerie
    Bourliere, Marc
    Ganne-Carrie, Nathalie
    de Ledinghen, Victor
    Bureau, Christophe
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2022, 46 (01)
  • [10] Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Eckel, F.
    Brunner, T.
    Jelic, S.
    ANNALS OF ONCOLOGY, 2011, 22 : vi40 - vi44